Diagnostic and therapeutic technology assessment. Surrogate markers of progressive HIV disease.
D000818:Animals; D001708:Biopterins / Q000031:analogs & derivatives / Q000032:analysis; D015496:CD4-Positive T-Lymphocytes; D015483:HIV Antibodies / Q000032:analysis; D016655:HIV Core Protein p24 / Q000032:analysis / Q000276:immunology; D015658:HIV Infections / Q000150:complications / Q000276:immunology*; D006801:Humans; D007958:Leukocyte Count; D008991:Monitoring, Physiologic; D019798:Neopterin; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control; D013673:Technology Assessment, Biomedical; D014122:Toxoplasma; D014123:Toxoplasmosis / Q000517:prevention & control; D001613:beta 2-Microglobulin / Q000032:analysis
D015483:HIV Antibodies; D016655:HIV Core Protein p24; D001613:beta 2-Microglobulin; D001708:Biopterins; D019798:Neopterin